NATCO Pharma Limited

NATCOPHARM.BO·BSE·Healthcare
Compare
796.45+6.85 (+0.87%)today
At close: Nov 5, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close789.60
Open797.80
Day range786.20809.65
52-week range660.051,340.45
Off day high−1.63%
Off 52-week high−40.58%
Volume79.68K
Avg. volume (3M)113.88K
Market cap142.65B
EPS (TTM)85.92
Forward P/E20.88
P/E ratio (TTM)9.27
Dividend yield0.77% (6.50)
Beta (5Y)0.12
Shares outstanding179.11M
Short interest—
Earnings dateNov 13, 2026
Analyst target970.36
Profit margin35.05%

Against its peers

Compare in full ›
NATCOPHARM.BO IPCALAB.BO GRANULES.BO SHILPAMED.NS INDSWFTLAB.BO MOREPENLAB.NS
Market cap 142.65B 494.67B 192.80B 180.29B 31.50B 53.21B
P/E (TTM) 9.3 37.8 35.3 65.1 37.0 28.3
Forward P/E 20.9 27.7 26.5 44.2 — —
Price/book 1.6 6.1 4.8 7.0 2.1 3.9
Dividend yield 0.77% 0.30% 0.26% 0.06% — 0.20%
1-year change −36.60% +51.51% +0.63% +152.54% +268.15% +113.46%
Today +0.87% −1.18% −0.01% −1.00% −4.09% −4.17%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Business Upturn·Positive

Natco Pharma closes Rs.12,794 million rights issue

Natco Pharma Limited completes Rs.12,794 million rights issue, closing on October 22, 2026, after the board's approval in September. Natco Pharma closes Rs.12,794 million rights issue Natco Pharma Limited, the renowned pharmaceutical…

Univest·Negative

Natco Pharma Ltd. 52 Week Low Streak: key stock context

Natco Pharma Ltd. 52 Week Low Streak has now extended to a second straight session, with the stock trading within 2% of its 52-week low across both days. Across the streak, the share price has moved down 2.23%, and the latest trading print…

Digital Health News·Positive

NATCO Pharma Raises Investment in eGenesis to $16.70 Mn

NATCO Pharma Limited has increased its proposed investment in US-based biotechnology company eGenesis, Inc. to $16.70 million from the previously announced $14 million, according to a regulatory filing. The investment will be made through…

From the 4Search news index, newest first.

In the news

7mentions in 30 days
7with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance